Renaming PCOS to PMOS: Implications for Women’s Health and Awareness
📰 Original title: What renaming PCOS to PMOS could mean for the future of women’s health
🤖 IA: It's not clickbait ✅
👥 Users: It's not clickbait ✅
View full AI summary: https://en.killbait.com/renaming-pcos-to-pmos-implications-for-women-s-health-and-awareness.html?utm_source=mastodon_social&utm_medium=social&utm_campaign=killbait_uk.mastodon_social

Renaming PCOS to PMOS: Implications for Women’s Health and Awareness
Polycystic ovary syndrome (PCOS) has officially been renamed polyendocrine metabolic ovarian syndrome (PMOS) following over a decade of advocacy and international consultation. This chronic condition, affecting approximately one in eight women globally, is associated with a wide array of health complications including diabetes, heart disease, depression, infertility, pregnancy difficulties, and reduced quality of life. The previous term, PCOS, was considered misleading because it suggested a disease primarily of the ovaries, whereas the condition’s key feature is disrupted follicle development due to hormonal and metabolic disturbances. The new designation, PMOS, aims to reflect the broader endocrine and metabolic aspects of the condition, as well as reduce stigma surrounding weight, mental health, and physical symptoms like acne and excess hair growth. The renaming process involved surveys and workshops with 22,000 patients and healthcare professionals, supported by 56 academic, clinical, and patient organisations, including Canadian and UK associations. With the transition expected to improve recognition, diagnosis, and treatment, the change also signals a commitment to patient-centred care, education, and research. Canadian experts emphasise that greater awareness among clinicians across multiple disciplines, from endocrinology to primary care, will be essential to ensure long-term support for women living with PMOS.








